Cipla in focus after partnership with MannKind
Most Popular (6 hours)

Mulk to release on July 27

- business-standard

Most Popular (24 hours)

2 women among 3 mauled by bear

- dailyexcelsior.com

Apps that win at localization

- business-standard

Most Popular (a week)

Govt signs MoU with NHA on PMRSSM

- dailyexcelsior.com

business-standard
12 days ago

Cipla in focus after partnership with MannKind

Cipla announced that it has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for Afrezza in India. Afrezza is the only USFDA approved inhaled insulin available for patients suffering from diabetes. The anno

Read on the original site


Hashtags:   

Cipla

 | 

focus

 | 

after

 | 

partnership

 | 

with

 | 

MannKind

 |